Concepedia

CDG Therapeutics (United States)

CT

Statistics

Publications

163

Citations

7.7K

Authors

12

Location

River Forest, United States

CDG Therapeutics (United States) is a company institution in River Forest, United States known for immunotherapy, medicine, and oncology.

HomepageROR

Top concepts

Publications

163

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

Howard A. Burris, Ian W. Flinn, Manish R. Patel et al. · The Lancet Oncology · 2018 · 205 citations

, , +16

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

Lawrence Steinman, Edward Fox, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2022 · 199 citations

, , +17

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma

Nathan Fowler, Felipe Samaniego, Wojciech Jurczak et al. · Journal of Clinical Oncology · 2021 · 161 citations · Full text

, , +13

Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study

Matthew S. Davids, Haesook T. Kim, Alyssa Nicotra et al. · The Lancet Haematology · 2018 · 115 citations · Full text

, , +15

A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis

Edward Fox, Amy E. Lovett‐Racke, Matthew Gormley et al. · Multiple Sclerosis Journal · 2020 · 115 citations · Full text

, , +17

1–5 of 163

Authors

12

  1. MW
    Michael Weiss

    CDG Therapeutics (United States), United States

    278 publications · 5.8K citations

    40

    h-index

  2. PS
    Peter Sportelli

    CDG Therapeutics (United States), United States

    139 publications · 2.5K citations

    23

    h-index

  3. HP
    Hari P. Miskin

    CDG Therapeutics (United States), United States

    109 publications · 1.8K citations

    19

    h-index

  4. MP
    Michelle Purdom

    CDG Therapeutics (United States), United States

    21 publications · 423 citations

    8

    h-index

  5. DW
    Danielle Wallace

    CDG Therapeutics (United States), United States

    53 publications · 102 citations

    6

    h-index

1–5 of 12